| Dr Sunil Sharma, MD | |
|
300 W 27th St, Lumberton, NC 28358-3075 | |
| (910) 671-5000 | |
| Not Available |
| Full Name | Dr Sunil Sharma |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 37 Years |
| Location | 300 W 27th St, Lumberton, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881614915 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 34733 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Catholic Home Care | Farmingdale, NY | Home health agency |
| Scotland Memorial Hospital | Laurinburg, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Carolina Emergency Physicians Pllc | 1355254947 | 12 |
News Archive
Kessler Foundation has received more than $718,000 in grant funding from the Craig Neilsen Foundation. The funding, comprised of five grants, supports a variety of rehabilitation research projects in spinal cord injury (SCI), including pain management, functional outcomes, quality of life, and factors affecting cognitive function.
The active agent ziconotide, the synthetic toxin of the cone snail (Conus magus), was acclaimed a safe alternative to morphine when it was introduced six years ago. Now it is increasingly suspected of causing patients to commit suicide.
The RRF Foundation for Aging awarded a multidisciplinary team from The University of Texas at Arlington with more than $160,000 for a project that explores the impact of reminiscence therapy and creation of digital memoirs on those diagnosed with Alzheimer's disease and related dementia.
Takeda Canada, Inc. is pleased to announce that ULORIC® (febuxostat), an innovative oral urate-lowering therapy to lower serum uric acid levels in patients with gout is now available in Canada. This medication is the first new treatment option in more than 40 years for the approximately three per cent of Canadians who have hyperuricemia associated with gout.1 ULORIC was discovered by Teijin Pharma Limited of Tokyo and licensed to Takeda for the Canada market.
Halozyme Therapeutics, Inc. today announced that AbbVie has dosed the first subject in a clinical trial evaluating the safety and pharmacokinetics of adalimumab with Halozyme's proprietary ENHANZE technology.
› Verified 8 days ago
| Entity Name | North Carolina Emergency Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003861386 PECOS PAC ID: 1355254947 Enrollment ID: O20031110000563 |
News Archive
Kessler Foundation has received more than $718,000 in grant funding from the Craig Neilsen Foundation. The funding, comprised of five grants, supports a variety of rehabilitation research projects in spinal cord injury (SCI), including pain management, functional outcomes, quality of life, and factors affecting cognitive function.
The active agent ziconotide, the synthetic toxin of the cone snail (Conus magus), was acclaimed a safe alternative to morphine when it was introduced six years ago. Now it is increasingly suspected of causing patients to commit suicide.
The RRF Foundation for Aging awarded a multidisciplinary team from The University of Texas at Arlington with more than $160,000 for a project that explores the impact of reminiscence therapy and creation of digital memoirs on those diagnosed with Alzheimer's disease and related dementia.
Takeda Canada, Inc. is pleased to announce that ULORIC® (febuxostat), an innovative oral urate-lowering therapy to lower serum uric acid levels in patients with gout is now available in Canada. This medication is the first new treatment option in more than 40 years for the approximately three per cent of Canadians who have hyperuricemia associated with gout.1 ULORIC was discovered by Teijin Pharma Limited of Tokyo and licensed to Takeda for the Canada market.
Halozyme Therapeutics, Inc. today announced that AbbVie has dosed the first subject in a clinical trial evaluating the safety and pharmacokinetics of adalimumab with Halozyme's proprietary ENHANZE technology.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sunil Sharma, MD 2600 N Elm St, Lumberton, NC 28358-3011 Ph: (910) 272-3051 | Dr Sunil Sharma, MD 300 W 27th St, Lumberton, NC 28358-3075 Ph: (910) 671-5000 |
News Archive
Kessler Foundation has received more than $718,000 in grant funding from the Craig Neilsen Foundation. The funding, comprised of five grants, supports a variety of rehabilitation research projects in spinal cord injury (SCI), including pain management, functional outcomes, quality of life, and factors affecting cognitive function.
The active agent ziconotide, the synthetic toxin of the cone snail (Conus magus), was acclaimed a safe alternative to morphine when it was introduced six years ago. Now it is increasingly suspected of causing patients to commit suicide.
The RRF Foundation for Aging awarded a multidisciplinary team from The University of Texas at Arlington with more than $160,000 for a project that explores the impact of reminiscence therapy and creation of digital memoirs on those diagnosed with Alzheimer's disease and related dementia.
Takeda Canada, Inc. is pleased to announce that ULORIC® (febuxostat), an innovative oral urate-lowering therapy to lower serum uric acid levels in patients with gout is now available in Canada. This medication is the first new treatment option in more than 40 years for the approximately three per cent of Canadians who have hyperuricemia associated with gout.1 ULORIC was discovered by Teijin Pharma Limited of Tokyo and licensed to Takeda for the Canada market.
Halozyme Therapeutics, Inc. today announced that AbbVie has dosed the first subject in a clinical trial evaluating the safety and pharmacokinetics of adalimumab with Halozyme's proprietary ENHANZE technology.
› Verified 8 days ago
Michael Bruss, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 300 W 27th St, Lumberton, NC 28358 Phone: 910-671-5000 | |
Erin Broderick, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 300 West 27th Street, Southeastern Health, Lumberton, NC 28359 Phone: 910-272-1478 Fax: 910-671-5392 | |
Dr. Bruce S. Whitman, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 W 27th St, Lumberton, NC 28358 Phone: 910-671-5000 | |
Dr. Karl Michael Duerr, M.D Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 W 27th St, Lumberton, NC 28358 Phone: 910-671-5000 | |
Jenna Santiago-wickey, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 W 27th St, Lumberton, NC 28358 Phone: 910-272-1478 Fax: 910-671-5392 | |
Dr. Aleksandr Pevtsov, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 W 27th St, Lumberton, NC 28358 Phone: 910-735-8783 | |
Douglas Nederostek, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 W 27th St, Lumberton, NC 28358 Phone: 910-671-5000 |